U.S. Oil and Gas Stock News

First quarter MRD momentum and guidance raise Adaptive Biotechnologies (ADPT) is back in focus after first quarter 2026 results highlighted strong Minimal Residual Disease, or MRD, revenue trends and a higher full year MRD revenue outlook of US$260 million to US$270 million. See our latest analysis for Adaptive Biotechnologies. The first quarter update has come alongside a 1-month share price return of 7.15% and a year to date share price decline of 7.67%. The 1-year total shareholder return...

Winmark (WINA) is in focus after the company outlined upcoming board changes, with long-serving director Lawrence A. Barbetta set to step down and marketing executive Stephanie S. Hoppe joining the board. See our latest analysis for Winmark. The board changes arrive after a softer run for the stock, with a 30-day share price return of a 13.0% decline and a 90-day share price return of an 18.7% decline. The 5-year total shareholder return of 120.1% points to much stronger longer term...

Key snapshot for Chimera Investment Chimera Investment (CIM) has drawn attention after recent share performance data, with the stock last closing at US$13.54 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for Chimera Investment. Recent trading has been choppy, with a 1-day share price return of -0.66% and a 7-day share price return of -1.53%. At the same time, the 1-year total shareholder return of 19.27% and 3-year total shareholder return of...

Liberty Global Ltd. has reported its first-quarter 2026 results, with sales rising to US$1,274.6 million and net income reaching US$337.8 million, compared with a net loss a year earlier. This move from a very large loss to positive earnings per share from continuing operations suggests a meaningful shift in the company’s recent operating performance. Next, we will examine how this return to quarterly profitability could affect Liberty Global’s investment narrative built around fiber and...

In early May 2026, Chesapeake Utilities Corporation reported first-quarter 2026 results showing higher sales of US$363 million, revenue of US$353.1 million, and net income of US$59.3 million, alongside an increase in diluted earnings per share from continuing operations to US$2.47 compared with a year earlier. At the same time, the company’s board approved a 7.3% increase in the quarterly dividend to US$0.735 per share, reinforcing its long-standing pattern of uninterrupted and annually...

In early May 2026, OSI Systems, Inc. reported third-quarter revenue of US$453.25 million and nine‑month revenue of US$1.30 billion, alongside slightly lower quarterly earnings, while reiterating its fiscal 2026 revenue guidance range of US$1.83 billion to US$1.87 billion. The combination of revenue growth, compressed margins, unchanged full‑year earnings guidance, and insider share sales has drawn attention to the company’s profitability trajectory and cost discipline. With profitability...

Q1 2026 earnings event reshapes the story Old Second Bancorp (OSBC) just posted Q1 2026 results that combine higher net income, a completed acquisition that expanded assets and footprint, and a clear rise in credit costs tied to problem loans. See our latest analysis for Old Second Bancorp. At a share price of $21.08, Old Second Bancorp has a year to date share price return of 8.21%. Its 1 year total shareholder return of 27.57% and 3 year total shareholder return of 95.98% point to momentum...

One of the biggest stories of last week was how Installed Building Products, Inc. ( NYSE:IBP ) shares plunged 25% in...

With inflation readings still elevated in many countries, bond yields reacting to every policy hint and trade flows shifting across regions, it is easy to feel stuck on the sidelines. One way to cut through the noise is to focus on founder-led companies where leadership has real skin in the game and capital is used carefully. This screener does exactly that, filtering for businesses where founders are still in charge and closely aligned with shareholders. In this article, you will see three...

Atmus Filtration Technologies (ATMU) is back in focus after reporting first quarter 2026 results, with higher sales and net income than a year ago, and reaffirmed full year 2026 earnings guidance. See our latest analysis for Atmus Filtration Technologies. The reaffirmed 2026 guidance and recent buyback activity come against a mixed trading backdrop, with a 1 day share price return of 1.09%, a 7 day share price decline of 13.50%, a year to date share price return of 4.64%, and a 1 year total...

Donnelley Financial Solutions recently reported first-quarter 2026 results showing revenue of US$205.5 million and net income of US$33.5 million, with earnings per share rising year on year. The company also issued second-quarter sales guidance and highlighted growing demand for its software platforms as clients adapt to evolving SEC reporting rules. Now we will examine how this earnings update and softer revenue guidance may influence Donnelley Financial Solutions’ existing investment...

Incyte Corporation ( NASDAQ:INCY ) announced strong profits, but the stock was stagnant. We did some digging, and we...

We wouldn't blame Intel Corporation ( NASDAQ:INTC ) shareholders if they were a little worried about the fact that...

Vital Farms (VITL) has drawn fresh investor attention after Q1 2026 results showed sales of US$187.16 million, alongside a net loss, a lower full year outlook, and a planned exit from its butter business. See our latest analysis for Vital Farms. The share price reaction has been severe, with a 1 day share price return of 20.7% and a year to date share price return of 68.1%. At the same time, the 1 year total shareholder return of 70.8% and 5 year total shareholder return of 52.2% point to...

National Vision Holdings is set to report its Q1 2026 results on May 13, with Wall Street expecting earnings per share of US$0.43 and revenue growth alongside higher comparable store sales. Analysts are watching for signs of improved operating leverage and margin performance, as well as how management characterizes consumer demand and competition across its optical retail formats. With expectations for higher earnings and mid-single-digit revenue growth, we'll examine how this upcoming...

Key earnings takeaways for Surgery Partners (SGRY) Surgery Partners (SGRY) kicked off 2026 with first quarter results that paired revenue growth with a narrower loss, while management reaffirmed full year guidance and highlighted ongoing cost discipline and portfolio work. The company reported Q1 revenue of US$810.9 million, basic and diluted loss per share from continuing operations of US$0.28, and an overall net loss of US$35.9 million. Management reiterated full year 2026 revenue guidance...

National Storage Affiliates Trust recently reported past first quarter 2026 results, with revenue of US$185.4 million and net income rising to US$17.78 million, lifting diluted earnings per share from continuing operations to US$0.16. Alongside this, an updated filing showed Prudential Financial and its subsidiaries collectively hold about 1.8% of the company’s common stock, highlighting continuing institutional interest in the self-storage REIT. With higher earnings per share despite...

If you are wondering whether Harmonic at US$12.28 is offering fair value or an opportunity, you will want to look past the headline share price and into what the valuation signals are really saying. The stock has recently shown sharp moves, with returns of 7.4% over the past week, 30.9% over the last 30 days, 22.6% year to date and 35.2% over the past year, set against a 22.8% decline over 3 years and a 78.2% gain over 5 years. Recent coverage around Harmonic has focused on its role as a...

Stock performance context for indie Semiconductor indie Semiconductor (INDI) has drawn fresh attention after a strong month, with the stock returning about 55% over that period, while the past 3 months show a gain of roughly 14%. For readers watching shorter term swings, the move comes after a modest 1 day decline of about 2% and a flat week, which contrasts with a year total return of around 93% and a 3 year loss near 44%. See our latest analysis for indie Semiconductor. At a share price of...

Wondering whether Silicon Motion Technology's current share price matches its underlying worth, or if expectations have simply raced ahead of fundamentals. The stock last closed at US$242.71, with returns of 10.9% over 7 days, 107.4% over 30 days, 158.9% year to date and 368.2% over the past year. This puts valuation questions front and center. Recent coverage has focused on the stock's sharp gains and what they might signal about investor confidence and changing risk perception. This kind...

Wilson Bank Holding (WBHC) opened 2026 with Q1 revenue of US$60.8 million and basic EPS of US$1.82, while trailing 12 month revenue stood at US$229.8 million and EPS was US$6.73, supported by earnings growth of 35.6% over the past year. Over recent periods the company has seen revenue move from US$181.7 million and EPS of US$4.79 on a trailing 12 month basis at Q4 2024 to US$219.9 million and EPS of US$6.28 by Q4 2025. This sets up the latest quarter against a track record of expanding profit...

Hill York Service, an EMCOR Group subsidiary, has been selected as the official HVAC partner for Inter Miami CF's new Nu Stadium. The agreement covers HVAC systems for the new venue and aligns EMCOR with a high profile sports facility project. This development adds a fresh angle to the EMCOR story beyond recent attention on quarterly results and guidance. For investors tracking EMCOR Group (NYSE:EME), the Hill York Service partnership with Inter Miami CF comes on top of a stock that has...

Backblaze (BLZE) drew fresh attention after first quarter 2026 results, with revenue of US$38.67 million and a net loss of US$6.15 million, alongside higher full year revenue guidance. See our latest analysis for Backblaze. The beat and raise has been met with sharp buying interest, with Backblaze’s share price at US$7.50 and a 30 day share price return of 107.18%, while the 1 year total shareholder return sits at 42.86%. This suggests strong recent momentum on expectations for AI related...

Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III data from LUCIDITY are expected next quarter. The company has also started a U.S. expanded access program so certain PBH patients can receive avexitide before any potential approval. Amylyx Pharmaceuticals focuses on therapies for serious neurological and metabolic conditions, with avexitide as its lead candidate for PBH. PBH can...